Mapping of a candidate region for susceptibility to inclusion body myositis in the human major histocompatibility complex

Abstract Inclusion body myositis (IBM) is a form of idiopathic inflammatory myopathy of unknown aetiology. A strong association with HLA class II (HLA-DR3) suggested a role for genes in the human major histocompatibility complex (MHC) in the predisposition to this disease. In this study, we have taken advantage of the ancestral haplotype (AH) concept and historical recombinations to map for a possible susceptibility gene(s) in the MHC. We performed detailed typing of three MHC-related HSP70 genes and defined allelic combinations in the context of MHC AH. We also modified existing methods to give a simple and accurate method for typing two TNF microsatellites. Using the HSP70 and TNF markers and HLA-DR, –B, and C4 typing of our patients with IBM, we defined a potential site for the MHC-associated susceptibility gene(s) in the region between HLA-DR and C4.

[1]  P. Bourque,et al.  Inclusion body myositis , 2024, Canadian Medical Association Journal.

[2]  I. Dunham,et al.  Identification of multiple HTF‐island associated genes in the human major histocompatibility complex class III region. , 1989, The EMBO journal.

[3]  A. Schmidt,et al.  RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. , 1996, Nature.

[4]  W. Fiers,et al.  Genes for the tumor necrosis factors alpha and beta are linked to the human major histocompatibility complex. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[5]  F. Christiansen,et al.  Ancestral haplotypes: conserved population MHC haplotypes. , 1992, Human immunology.

[6]  A. Cambon-Thomsen,et al.  Microsatellite, restriction fragment-length polymorphism, and sequence-specific oligonucleotide typing of the tumor necrosis factor region. Comparisons of the 4AOHW cell panel. , 1993, Human immunology.

[7]  A. Cambon-Thomsen,et al.  Extensive genetic polymorphism in the human tumor necrosis factor region and relation to extended HLA haplotypes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[8]  C. Carcassi,et al.  Updated characterization of ancestral haplotypes using the Fourth Asia-Oceania Histocompatibility Workshop panel. , 1995, Human immunology.

[9]  A. Pugliese,et al.  Gametic association of HSP70-1 promoter region alleles and their inclusion in extended HLA haplotypes. , 1993, Tissue antigens.

[10]  L. Strong,et al.  Human C4 haplotypes with duplicated C4A or C4B. , 1984, American journal of human genetics.

[11]  A. Svejgaard,et al.  HLA and Disease 1982 ‐ A Survey , 1983, Immunological reviews.

[12]  I. Dunham,et al.  Human major histocompatibility complex contains genes for the major heat shock protein HSP70. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[13]  D. Chaplin,et al.  Highly informative typing of the human TNF locus using six adjacent polymorphic markers. , 1993, Genomics.

[14]  C. Carcassi,et al.  Updated characterization of the fourth ancestral haplotypes using Asia-Oceania Histocompatibility Workshop panel , 1995 .

[15]  M. Baur,et al.  Insulin-Dependent Diabetes Mellitus , 1984 .

[16]  Chou Sm,et al.  Inclusion body myositis. , 1993 .

[17]  I. Udalova,et al.  DNA sequence polymorphism at the human tumor necrosis factor (TNF) locus. Numerous TNF/lymphotoxin alleles tagged by two closely linked microsatellites in the upstream region of the lymphotoxin (TNF-beta) gene. , 1991, Journal of immunology.

[18]  A. Engel,et al.  Monoclonal antibody analysis of mononuclear cells in myopathies. II: Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis , 1984, Annals of neurology.

[19]  E M Wijsman,et al.  Toward localization of the Werner syndrome gene by linkage disequilibrium and ancestral haplotyping: lessons learned from analysis of 35 chromosome 8p11.1-21.1 markers. , 1996, American journal of human genetics.

[20]  M. Dalakas.  Polymyositis, dermatomyositis and inclusion-body myositis. , 1991, The New England journal of medicine.

[21]  A. Svejgaard.  HLA and disease. , 1977, Revue francaise de transfusion et immuno-hematologie.

[22]  R. Tisch,et al.  Insulin-Dependent Diabetes Mellitus , 1996, Cell.

[23]  L. Tsui,et al.  Erratum: Identification of the Cystic Fibrosis Gene: Genetic Analysis , 1989, Science.

[24]  S. Dimauro,et al.  Inclusion body myositis and myopathies , 1995, Annals of neurology.

[25]  H. Orr,et al.  Linkage map of the human major histocompatibility complex including the tumor necrosis factor genes. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[26]  X. Chen,et al.  RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease , 1996, Nature.

[27]  F. Mastaglia,et al.  Treatment of inflammatory myopathies , 1997, Muscle & nerve.

[28]  L. Tsui,et al.  Identification of the cystic fibrosis gene: genetic analysis. , 1989, Science.

[29]  I. Dunham,et al.  Molecular mapping of the human major histocompatibility complex by pulsed-field gel electrophoresis. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Strominger,et al.  Human major histocompatibility complex contains a minimum of 19 genes between the complement cluster and HLA-B. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[31]  W. Engel,et al.  New advances in the understanding of sporadic inclusion‐body myositis and hereditary inclusion‐body myopathies , 1995, Current opinion in rheumatology.

[32]  F. Christiansen,et al.  Differences in gene copy number carried by different MHC ancestral haplotypes. Quantitation after physical separation of haplotypes by pulsed field gel electrophoresis , 1990, The Journal of experimental medicine.

[33]  F L Mastaglia,et al.  HLA associations with inclusion body myositis , 1994, Clinical and experimental immunology.

[34]  J. Strominger,et al.  A new cluster of genes within the human major histocompatibility complex. , 1989, Science.

[35]  W. Hurley,et al.  Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. , 1992, The Journal of biological chemistry.